Figure 2. Overall and Event-Free Survival Among Patients in the Children’s Oncology Group AAML1331 and AAML0631 Studies by Risk Group.
The AAML0631 study included 66 patients with standard-risk APL and 35 patients with high-risk APL. The AAML1331 study included 98 patients with standard-risk APL and 56 patients with high-risk APL. APL indicates acute promyelocytic leukemia; EFS, event-free survival; and OS, overall survival.